The intravenous (IV) equipment market in South Africa has grown strongly, owing mostly to an increase in the frequency of chronic diseases requiring continuous medical interventions as well as developments in healthcare infrastructure across the country. IV catheters, infusion pumps, administration sets, and accessories are among the products available in the IV equipment market. The increased demand for effective and precise drug delivery systems is a major driver driving the market's rise. South African healthcare providers are increasingly using modern IV technology to ensure exact dosage delivery and reduce the possibility of pharmaceutical errors. With a focus on improving patient outcomes and minimising healthcare-associated infections, there is a rising preference for technologically advanced and safer IV equipment. The market for IV catheters, which are critical in obtaining vascular access for infusion therapy, has grown significantly. In order to reduce the occurrence of needlestick injuries and infections, manufacturers are working on producing catheters with better safety features. Furthermore, the rising prevalence of chronic disorders such as diabetes, cancer, and cardiovascular disease has increased demand for infusion therapy, pushing IV catheter sales. Government initiatives targeted at strengthening healthcare infrastructure and providing access to excellent medical services, particularly in rural areas, are expected to drive IV equipment demand in South Africa even further. Medical devices are subject to a rigorous regulatory process in South Africa. SAHPRA's Medical Devices Unit oversees the licencing of medical device companies as well as the registration of medical devices. South Africa also has a company that specialises in the manufacture and delivery of IV treatment medical devices. VIVAline™ is a licenced SAHPRA medical manufacturer and supplier. South Africa has seen a rise in demand for IV drips since their launch in 2015.
According to the research report, "South Africa Intravenous Equipment Market Overview, 2031," published by Bonafide Research, the South Africa Intravenous Equipment market is anticipated to grow at more than 6.78% CAGR from 2026 to 2031. South Africa's healthcare industry has several unique aspects related to the intravenous (IV) equipment market. The country's concerted attempts to alleviate healthcare inequities among its varied population are one key component. While South Africa has a growing healthcare infrastructure, it has issues such as accessibility, especially in rural and neglected areas. The IV equipment market reflects this contrast, with urban areas seeing higher adoption rates of modern IV technology than rural areas, where accessibility remains an issue. Another noteworthy aspect is the increased emphasis on public-private partnerships and attempts to improve healthcare. The South African government works with commercial organisations to improve healthcare facilities and encourage the use of modern IV technology, with the goal of closing gaps in healthcare access and improving patient outcomes. This collaborative approach affects market dynamics by stimulating innovation and the launch of cost-effective yet technologically superior IV solutions to serve a broader demographic. The demographic and epidemiological landscape also has an impact on the IV equipment industry. South Africa faces a high illness burden, including HIV/AIDS, TB, and non-communicable diseases (NCDs) such as diabetes and cardiovascular disease. This health profile has an impact on the need for IV equipment, particularly infusion pumps and catheters, which are essential in administering medicines for chronic illnesses that require long-term maintenance.
In South Africa’s intravenous (IV) equipment market, product demand is shaped by essential care needs and a growing focus on precision and safety in clinical practice. IV catheters remain one of the most widely used products across the country due to their fundamental role in establishing vascular access, which is required for nearly all IV therapies. These devices are indispensable in hospitals, emergency departments, and outpatient clinics where fluid replacement, drug administration, blood transfusion, and critical care treatments are performed daily. High quality catheters especially peripheral types are predominantly used due to their ease of placement, reliability, and cost effectiveness. IV infusion pumps are another significant product segment and are gaining increased prominence within the market. The South African infusion pump landscape generated notable revenue in recent years, with volumetric infusion pumps leading in value due to widespread use in hydration therapy, parenteral nutrition, blood transfusions, and emergency care. These devices are prized in intensive care units and surgical wards for their ability to deliver precise volumes of fluids and medications with programmable controls and safety alerts. Syringe pumps also play a key role especially in neonatal, pediatric, oncology, and palliative care offering accuracy for low dose drug administration. Insulin and elastomeric pumps are becoming more common in diabetic care and home based treatment, reflecting a shift toward convenience and patient centric care models.
A Bonafide Research industry report provides in-depth market analysis, trends, competitive insights, and strategic recommendations to help businesses make informed decisions.
Download Sample
We are friendly and approachable, give us a call.